bpc-157 human studies safety evidence clinical trials BPC-157: What you need to know before you The Hidden Risks of BPC‑157:

While some patients do report noticeable improvements within the first few days, the reality is that meaningful results typically develop over a period of weeks

In a 2-year trial involving patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk, more events of diabetic retinopathy complications occurred in patients treated with semaglutide 0.5 and 1 mg once weekly injections (3%) compared to placebo (1.8%)

2020;106(3):e1481e1487

Once you have set up realistic and achievable goals for yourself, you need to stay dedicated, consistent, and patient with your progress

A 2020 study in Current Pharmaceutical Design confirmed that BPC 157 promotes the NO (nitric oxide) system, which plays a direct role in blood vessel formation and tissue protection